INS and cancer: Taking into consideration the inhibition of insulin/IGF-I signaling pathways induced by E-cadherin expression, we went further and assessed the impact of Insulin and IGF-I signaling pathways in the modulation of bisecting GlcNAc N-glycans expression, in MDA-MB-435 cancer cells.